Announcements Trials

Browse Landscape

Phase

Status

Completed 9 Terminated 3 Withdrawn 2 Unknown 2 Not yet recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 430 Neoplasms 284 Carcinoma, Non-Small-Cell Lung 266 Colorectal Neoplasms 228 Lung Neoplasms 173 Prostatic Neoplasms 171 Carcinoma, Hepatocellular 156 Stomach Neoplasms 129 Leukemia, Myeloid, Acute 118 Pancreatic Neoplasms 115 Multiple Myeloma 105 Recurrence 96 Uterine Cervical Neoplasms 91 Squamous Cell Carcinoma of Head and Neck 88 Neoplasm Metastasis 87 Rectal Neoplasms 85 Ovarian Neoplasms 77 Triple Negative Breast Neoplasms 75 Small Cell Lung Carcinoma 72 Head and Neck Neoplasms 68 Brain Neoplasms 68 Esophageal Neoplasms 64 Glioblastoma 63 Colonic Neoplasms 60 Endometrial Neoplasms 58 Melanoma 54 Hematologic Neoplasms 53 Motor Activity 50 Precursor Cell Lymphoblastic Leukemia-Lymphoma 48 Nasopharyngeal Carcinoma 46

Interventions

ceterizine hydrochloride 1 capivasertib 1 Loperamide 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × Exanthema × Clear all

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting

Diarrhea, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡